Epicardial injection of allogeneic human-induced-pluripotent stem cell-derived cardiomyocytes in patients with advanced heart failure: protocol for a phase I/IIa dose-escalation clinical trial

INTRODUCTION: Heart failure (HF) is a growing global public health burden. However, due to the very limited regenerative capacity of mature cardiomyocytes in the adult mammalian heart, conventional treatments can only improve the symptoms of HF but fail to restore cardiac function. Heart transplanta...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, He, Xue, Yunxing, Pan, Tuo, Zhu, Xiyu, Chong, Hoshun, Xu, Can, Fan, Fudong, Cao, Hailong, Zhang, Bomin, Pan, Jun, Zhou, Qing, Yang, Gang, Wang, Jiaxian, Wang, Dong-Jin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2022
Materias:
Cardiovascular Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9083430/
https://www.ncbi.nlm.nih.gov/pubmed/35523485
http://dx.doi.org/10.1136/bmjopen-2021-056264

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9083430/
https://www.ncbi.nlm.nih.gov/pubmed/35523485
http://dx.doi.org/10.1136/bmjopen-2021-056264

Ejemplares similares